Biotechnology News and Research

RSS

Building the next generation of DMTA for future-ready drug discovery

Discover how the next generation of DMTA is creating a future-ready drug discovery engine through AI and automation.

From TTP plc 15 Jul 2026

How to overcome purification bottlenecks in modern drug discovery

Learn how to overcome purification bottlenecks in modern drug discovery with advanced purification strategies, streamlined workflows, and automation.

From TTP plc 15 Jul 2026

Unlocking the potential of organoids in modern drug discovery

Explore how organoids are unlocking new possibilities in modern drug discovery by improving disease modelling within DMTA-driven research workflows.

From TTP plc 15 Jul 2026

Insilico and Bora Pharmaceuticals forge strategic AI-driven drug discovery alliance

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced a multi-target strategic alliance with Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing.

14 Jul 2026

Stealth nanoparticles improve pancreatic cancer treatment with fewer side effects

Pancreatic cancer is considered one of the most lethal cancer because it is often diagnosed late and is difficult to treat.

14 Jul 2026

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Frances Arnold on directed enzyme evolution: random mutation plus smart screening, and why it changed enzyme engineering and industry.

From Pittcon 14 Jul 2026

EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy

EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro ("ClearPoint"), a global therapy-enabling company offering precise navigation and delivery to the brain, today announced a partnership to support the targeted delivery of EpilepsyGTx's lead gene therapy candidate, EPY201, for focal refractory epilepsy (FRE).

From EpilepsyGTx 14 Jul 2026

Study links chronic xanthan gum consumption to colon inflammation

Xanthan gum is found almost everywhere. This food additive has thickening, stabilizing, and gelling properties and is one of the most widely used by the food industry to adjust the consistency of ice cream, yogurt, cakes, sauces, and gluten-free pasta.

13 Jul 2026

New genetic reference map accelerates human stem cell research

A team led by bioengineers at the University of California San Diego has developed a genome-scale reference map that details how individual genes control the functions and identities of human stem cells.

13 Jul 2026

Engineered ribozyme repairs broken RNA to explain origins of life

In most modern cells, DNA stores the genetic blueprint, and relies on proteins to replicate, repair and build from those blueprints.

13 Jul 2026

Harvard University hosts the world's largest conference dedicated to longevity biotechnology

The 13th Aging Research & Drug Discovery (ARDD) Meeting, the world's largest conference dedicated to longevity biotechnology, will take place from October 1-3, 2026, at the David Rubenstein Treehouse at Harvard University.

11 Jul 2026

Insilico Medicine founder to highlight sustainable longevity at BIO Asia-Taiwan

Dr. Alex Zhavoronkov, Founder and CEO of Insilico Medicine, has been invited to attend BIO Asia-Taiwan, which will be held from July 15 to 19 in Taiwan, China.

11 Jul 2026

Cruise ship pollution increases risk of viral infections in ports

Air pollution from cruise ships could be damaging the health of people living in port cities by increasing inflammation and susceptibility to viruses such as the common cold and COVID-19.

11 Jul 2026

Exposure to port-derived particles facilitates the replication of COVID-19 and cold viruses

Air pollution from cruise ships could be damaging the health of people living in port cities by increasing inflammation and susceptibility to viruses such as the common cold and COVID-19.

10 Jul 2026

Experimental compound BA-101 overcomes chemotherapy resistance in glioblastoma

Scientists have identified a promising new strategy to tackle one of the biggest obstacles in treating glioblastoma, one of the most aggressive form of brain cancer: resistance to chemotherapy.

9 Jul 2026

Study identifies new target for Parkinson's disease neuroprotection

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

8 Jul 2026

Toronto researchers uncover genetic drivers of triple negative breast cancer

Researchers have solved a long-standing mystery of how abnormal chromosomes drive cancer, identifying 81 new genes involved in aggressive breast cancer.

8 Jul 2026

New gene therapy strategy uses the brain's own glymphatic transport system for drug delivery

A new study describes a gene therapy strategy that uses the brain's own glymphatic transport system to distribute engineered viral vectors throughout the brain.

8 Jul 2026

Molecular changes in the liver of space travelers provide clues about aging

What happens to the human body in space may help scientists create new anti-aging therapies.

7 Jul 2026

Eppendorf focuses outreach programs to advance STEM education in Europe

Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, today highlights its European outreach activities dedicated to addressing persistent challenges in STEM education.

From Eppendorf 7 Jul 2026